Table 4.
Logistic regression of probability of hospitalization of cystic fibrosis patients, N = 804.
| AOR* | 95% CI | |
|---|---|---|
| Overall adherence with TIS | ||
| Low (reference) | 1.0 | |
| Medium | 0.94 | 0.62-1.41 |
| High | 0.40 | 0.19-0.84 |
| Age (in years) | ||
| <6 (reference) | 1.0 | |
| 6-10 | 1.76 | 0.89-3.47 |
| 11-17 | 1.52 | 0.86-2.69 |
| 18-25 | 1.48 | 0.80-2.73 |
| ≥26 | 0.73 | 0.38-1.39 |
| Gender | ||
| Male (reference) | 1.0 | |
| Female | 1.04 | 0.74-1.44 |
| Comorbidity score | ||
| ≤Average (reference) | 1.0 | |
| >Average | 7.53** | 5.20-10.90 |
| Selected comorbidity | ||
| Pseudomonas aeruginosa | 3.0** | 2.13-4.32 |
| Failure to thrive/growth failure | 2.8** | 1.09-7.14 |
*Adjusted for variables in the table and health plan type and geographic residence; **p < 0.05
AOR = adjusted odds ratio; CI = confidence interval; TIS = tobramycin